Detalles de la búsqueda
1.
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 16(3): 320-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25702876
2.
Role of 18F-Choline PET/CT in the Initial Staging of High Risk Prostate Cancer and Comparison with Conventional Imaging Techniques.
Arch Esp Urol
; 75(8): 684-692, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36330569
3.
Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study.
Radiat Oncol
; 15(1): 137, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487218
4.
Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
Radiother Oncol
; 141: 156-163, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570236
5.
Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys
; 96(2): 341-348, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27598804
6.
Role of 18F-Choline PET/CT in the Initial Staging of High Risk Prostate Cancer and Comparison with Conventional Imaging Techniques
Arch. esp. urol. (Ed. impr.)
; 75(8): 684-692, 28 sept. 2022. tab, graf, ilus
Artículo
en Inglés
| IBECS (España) | ID: ibc-212094
Resultados
1 -
6
de 6
1
Próxima >
>>